University of British Columbia
Long-term outcomes of antibiotic treatments in fecal microbiota transplantation donors on microbiota composition, function, and antibiotic resistance genes
Abstract
dc:descriptionFecal Microbiota Transplantation (FMT) serves as a primary treatment option for recurrent Clostridioides difficile Infection (rCDI) and is under clinical trial for diseases like Inflammatory Bowel Disease (IBD). Its core objective is to rebalance the gut microbiota, relying on the selection of safe donor samples. This choice is critical; a well-matched donor sample can restore healthy gut flora and facilitate treatment, while an unsuitable one might introduce dangerous pathogens. Amidst these considerations, a substantial knowledge gap exists concerning the consequences of antibiotic consumption by potential donors. Specifically, the effects of antibiotics on donor samples and their duration of impact, as well as the timeframe for reusing the same donors for FMT after antibiotic exposure, remain uncertain. This study investigates the antibiotic-induced alterations in donor samples, focusing on changes during and post-antibiotic treatment. I conducted a longitudinal analysis of samples from three donors, employing high-throughput metagenomics sequencing to assess the enduring effects of antibiotics on bacterial diversity, composition, functions, and the phageome. Results indicate substantial antibiotic impacts on the microbial community at species and strain levels, affecting key bacteria necessary for FMT success, including SCFA-producing bacteria like Eubacterium hallii and Bifidobacterium bifidum, which is also known as a highly engrafting bacterium. Moreover, antibiotics affect the functionality of the bacterial community, mainly affecting housekeeping genes. However, the relationship between these affected functional changes and FMT success remains unexplored. I also observed only minimal changes in viral populations, with their relevance to FMT success remaining unexplored. Additionally, no significant increase was found in the development of serious Antibiotic Resistance Genes (ARGs), which contrasts with my initial expectations of major shifts in ARGs. This study underscores the notion that donors who have previously consumed antibiotics may not be ideal candidates for subsequent FMT procedures and applications due to the changes occurring in their gut microbiota, which extend beyond alterations in ARGs. It's crucial to note that safety concerns regarding the accumulation of ARGs do not seem to be substantiated by findings of this study. Also, customizing suspension periods with detailed analysis can better gauge the microbiota's recovery.
Degree
thesis:*- Name thesis:degree_name
- Master of Applied Science - MASc
- Level thesis:degree_level
- master's
- Discipline thesis:degree_discipline
- Mechanical Engineering
- Grantor dc:publisher
- University of British Columbia
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Karimianghadim, Ramin
- Contributors dc:contributor
-
- Pakpour, Sepideh
Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- http://hdl.handle.net/2429/87867